Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Clinical trials have shown promising results for Tirzepatide, with patients losing an average of 11 to 13.1% of their body weight over six months in a phase 2 trial, and even more encouraging results in phase 3 trials
A personalized treatment plan that considers the patients overall health and specific conditions is important
6.9% placebo
Improved Liver Function The liver is one of the first organs affected by obesity its often where we see early signs of damage, like fatty liver disease
US$ 29.21
US$ 28.26
US$ 29.41
US$ 20.68
US$ 24.67
US$ 20.03
US$ 22.77
